Abstract:Licui Li, 1, 2 Huixiu Lu, 1, 3 Yanli Zhang, 4 Qian Li, 4 Shaomin Shi, 4 Yaling Liu 1, 4 1 Department of Dermatology and Venereology, Hebei Medical University, Shijiazhuang, People's Republic of China; 2 Department of Dermatology, Shijiazhuang Gaocheng People's Hospital, Shijiazhuang, People's Republic of China; 3 Department of Dermatology, Shijiazhuang People's Hospital, Shijiazhuang, People's Republic of China; 4 Department of Dermatology, The Third Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China Correspondence: Yaling Liu, Department of Dermatology and Venereology, Hebei Medical University, Shijiazhuang, People's Republic of China, Email Objective: To probe into the effect of azelaic acid on psoriasis based on the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) signaling pathway. Methods: Psoriasis gene expression data were downloaded from the GEO database for differential expression analysis to identify differentially expressed genes (DEGs). KEGG and GSEA analyses were performed to identify important signaling pathways that may be involved in psoriasis progression for subsequent validation. Thirty-six C57BL/6 mice aged 8 weeks old were randomly assigned into the blank control group (n = 9), negative control group (n = 9), psoriasis model group (n = 9), and azelaic acid treat group (n = 9). Mice models of psoriasis were prepared with imiquimod (IMQ) in the latter two groups, and azelaic acid ointment was applied in azelaic acid treat group. Then, hematoxylin-eosin (HE) staining was carried out to detect the effect of azelaic acid on the pathological damage of mice models of psoriasis in each group. HaCaT cells cultured in vitro were divided into blank control group, negative control group (addition of azelaic acid), IL-17 group (20 ng/mL) and IL-17+azelaic acid group, with 3 replicates for each group. Immunofluorescence assay and Western blotting were used to detect the protein expression of PI3K/AKT signaling pathway related molecules. Results: KEGG analysis showed that DEGs were significantly enriched in PI3K-AKT signaling pathway. GSEA analysis showed that PI3K and MTOR signaling pathways were up-regulated in psoriasis, while AUTOPHAGY signaling pathway was down-regulated. HE staining showed that azelaic acid could significantly inhibit the local skin injury in mice caused by IMQ-induced psoriasis. Moreover, azelaic acid can inhibit the expression of PI3K/AKT signaling pathway related proteins phosphorylated (p)-PI3K, p-AKT, p-mammalian target of rapamycin (mTOR), vascular endothelial growth factor (VEGF), cyclooxygenase-2 (COX-2), angiogenin-1 and hypoxia-inducible factor-1α (HIF-1α). These results imply that azelaic acid may inhibit the activation of PI3K/AKT signaling pathway and angiogenesis, thereby improving the symptoms of psoriasis. Conclusion: Azelaic acid may inhibit the activation of PI3K/AKT signaling pathway and angiogenesis, thereby improving the symptoms of psoriasis. Keywords: psoriasis, azelaic acid, PI3K/AKT signaling pathway, angiogenesis Psoriasis is a chronic inflammatory dermatosis, which has strong genetic susceptibility and autoimmune pathogenic characteristics. 1 Currently, it is believed that psoriasis has an association with genetic, environmental, immune and other factors. It is mediated by the innate and adaptive immune systems, involves multiple links and pathways, and notably affects the health and quality of life of patients. 2,3 Phosphatidylinositol‐4,5‐bisphosphate 3‐kinase (PI3K)/protein kinase B (AKT) signaling pathway is a key pathway for cell survival and a typical autophagy-dependent transduction pathway, which is involved in cell growth, proliferation, vascular proliferation and other processes. 4 PI3K in cells can be activated by corresponding cytokines, further activating downstream AKT and related proteins and triggering corresponding cellular effects. In psoriasis, this pathway can regulate the upstream and downstream related targets together to induce pathological proliferation of epidermal cells. 5 In the upstream, tumor suppressor phosphatase and tensin homolog (PTEN) expression is down-regulated, and in the downstream, mammalian target of rapamycin (mTOR) is abnormally expressed. Inhibiting the PI3K/AKT signaling pathway can repress endothelial growth factors, thereby relieving the symptoms of psoriasis. 6 Azelaic acid gel is a common anti-inflammatory drug. It is mostly used in the treatment of acne, chloasma and cutaneous lesions caused by ultraviolet rays in clinic. 7–9 It can effectively improve the damaged skin barrier function of pati -Abstract Truncated-

p38α deficiency ameliorates psoriasis development by downregulating STAT3-mediated keratinocyte proliferation and cytokine production

P38α Signaling in Langerhans Cells Promotes the Development of IL-17–producing T Cells and Psoriasiform Skin Inflammation

Transglutaminase 3 attenuates skin inflammation in psoriasis by inhibiting NF-κB activation via p-STAT3-TET3 signaling.

IL-17A exacerbates psoriasis in a STAT3 overexpressing mouse model

Association between psoriasis and STAT3

Heme oxygenase-1 induction attenuates imiquimod-induced psoriasiform inflammation by negative regulation of Stat3 signaling

The P38‐interacting Protein P38ip Suppresses TCR and LPS Signaling by Targeting TAK1

Protein inhibitor of activated STAT3 (PIAS3) attenuates psoriasis and associated inflammation

Tetrastigma hemsleyanum polysaccharides alleviate imiquimod-induced psoriasis-like skin lesions in mice by modulating the JAK/STAT3 signaling pathway

P38α deficiency in macrophages ameliorates murine experimental colitis by regulating inflammation and immune process

OAS1, OAS2, and OAS3 Contribute to Epidermal Keratinocyte Proliferation by Regulating Cell Cycle and Augmenting IFN-1‒Induced Jak1‒Signal Transducer and Activator of Transcription 1 Phosphorylation in Psoriasis.

Impaired. Function of Regulatory T Cells in Patients with Psoriasis is Mediated by Phosphorylation of Stat3

Il-37 Ameliorates The Inflammatory Process In Psoriasis By Suppressing Proinflammatory Cytokine Production

Dysfunction of regulatory T cells in patients with psoriasis and related mechanisms of regulation by the STAT3 signaling pathway

IL-35 Decelerates the Inflammatory Process by Regulating Inflammatory Cytokine Secretion and M1/M2 Macrophage Ratio in Psoriasis

Alpha-7 nicotinic acetylcholine receptor agonist alleviates psoriasis-like inflammation through inhibition of the STAT3 and NF-κB signaling pathway

Uncoupling melanogenesis from proliferation in epidermal melanocytes responding to stimulation with psoriasis-related proinflammatory cytokines

PTPN2 inhibits the proliferation of psoriatic keratinocytes by dephosphorylation of STAT3

Effect of Azelaic Acid on Psoriasis Progression Investigated Based on Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (AKT) Signaling Pathway

E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis.

Activation of the C3a Anaphylatoxin Receptor Inhibits Keratinocyte Proliferation by Regulating Keratin 6, Keratin 16, and Keratin 17 in Psoriasis